Even when clinical criteria are met, many regional BCBS plans classify Wegovy as a lifestyle medication rather than a medical necessity, placing it in higher cost-sharing tiers with substantial copayments or coinsurance obligations
Placebo-controlled superiority trials in type 2 diabetes (T2D) LEADER, SUSTAIN-6, REWIND, and SOUL and in obesity without diabetes (SELECT) demonstrated statistically significant reductions in major adverse cardiovascular events (MACE) of approximately 12%26% [3], [4], [10][12]
The needles used for administration are insulin style, which are very small and thin
Toms JA, ONeill E, Wiegmann AL, Adepoju J, Raj MS
In mice, weight loss happened with no change in food intake at all, so the animal data points to altered fat metabolism rather than appetite suppression
3 (download XLSX Statistical source data